BioSpace News Archive

Drug Development

Regeneron and Sanofi‘s Blockbuster Drug Hits the Mark in Two Phase III trials

Shares of Regeneron jumped more than 5 percent Monday after the company announced that its blockbuster drug Dupixent (dupilumab) hit the mark in two Phase III trials studying the drug as a treatment for adults with inadequately-controlled chronic rhinosinusitis with nasal polyps.

October 17, 2018
·
3 min read
·
Alex Keown
Business

With $54 Million in Hand, Startup CuraSen Takes Aim at Parkinson’s and Alzheimer’s

San Mateo, Calif.-based startup CuraSen Therapeutics surged forward this morning with $54.5 million in Series A funding and a leadership team that includes executives from Afferent Pharmaceuticals, a company acquired by Merck in 2016 for $1.2 billion.

October 17, 2018
·
2 min read
·
Alex Keown
Business

CuraSen Therapeutics Announces $54.5 Million Series A Financing with Industry Veterans at Helm to Develop Drugs Targeting Novel Mechanism for the Treatment of Neurodegenerative Diseases

CuraSen Therapeutics, Inc., a privately held biotechnology company focused on developing therapies to treat neurodegenerative diseases, today announced the closing of a $54.5 million Series A financing.

October 17, 2018
·
3 min read
Drug Development

Neurana Pharmaceuticals to Present Tolperisone Phase 1 Clinical Data at the 2018 ACR/ARHP Annual Meeting

Presentation will highlight data demonstrating the non-sedating effects of tolperisone

October 17, 2018
·
2 min read
Biotech Beach

Anixa Biosciences Releases Data Presented at AACR Artificial Intelligence Conference

Anixa Biosciences presented the results from its ongoing study utilizing Cchek™.

October 17, 2018
·
3 min read
Drug Development

ArQule to Report Third Quarter 2018 Financial Results on October 31, 2018

ArQule, Inc. today announced it will report financial results for the third quarter of 2018 before the market opens on Wednesday, October 31, 2018.

October 17, 2018
·
2 min read
BioMidwest

Adhesive Innovation Helps Clinicians Confidently Meet the Most Challenging Demands of Critical Tube Securement

New 3M™ Durapore™ Advanced Surgical Tape provides exceptional adhesion to meet clinicians’ securement needs

October 17, 2018
·
4 min read
BioCapital

IDT Biologika Awarded 10-Year NIH Contract to Manufacture Vaccines and Biologics for Infectious Diseases

The total funding could be up to $80 million over the course of the contract if all project milestones are met.

October 17, 2018
·
3 min read
Allergan Announces Completion of Two Positive Safety Studies for Ubrogepant - an Oral CGRP Receptor Antagonist for the Acute Treatment of Migraine

One-year study continues to support positive safety and tolerability profile for ubrogepant

October 17, 2018
·
7 min read
Drug Development

Oragenics, Inc. Receives Clearance to Enroll Patients in Belgium into Its Phase 2 Clinical Trial of AG013 for Oral Mucositis

Phase 2 clinical trial of AG013, a live biotherapeutic product for the potential prevention and treatment of OM.

October 17, 2018
·
3 min read